Pulmonary toxicity of cardiac drugs
(c) 1999 Prous Science. All rights reserved..
Pulmonary damage caused by the undesired effects of cardiac drugs is being increasingly recognized. With the symptoms of breathlessness, wheeze, cough and hemoptysis common to both cardiac and respiratory diseases, an adverse pulmonary reaction to a cardiac drug may be mistakenly attributed to deterioration of cardiac status. This is especially true if the onset of symptoms are subacute or chronic. The pulmonary side effects of cardiac drugs are varied and may actually mimic the disease being treated. It is essential that the clinician remain highly suspicious that new and unexplained pulmonary symptoms and signs may be drug-related. Most of the side effects are reversible with early drug cessation and subsequent challenge should be avoided if possible.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
1999 |
|---|---|
| Erschienen: |
1999 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Drugs of today (Barcelona, Spain : 1998) - 35(1999), 11 vom: 13. Nov., Seite 867-78 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kedia, R K [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.10.2003 Date Revised 07.11.2019 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM127203729 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM127203729 | ||
| 003 | DE-627 | ||
| 005 | 20231222213500.0 | ||
| 007 | tu | ||
| 008 | 231222s1999 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0424.xml |
| 035 | |a (DE-627)NLM127203729 | ||
| 035 | |a (NLM)12973378 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kedia, R K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pulmonary toxicity of cardiac drugs |
| 264 | 1 | |c 1999 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2003 | ||
| 500 | |a Date Revised 07.11.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a (c) 1999 Prous Science. All rights reserved. | ||
| 520 | |a Pulmonary damage caused by the undesired effects of cardiac drugs is being increasingly recognized. With the symptoms of breathlessness, wheeze, cough and hemoptysis common to both cardiac and respiratory diseases, an adverse pulmonary reaction to a cardiac drug may be mistakenly attributed to deterioration of cardiac status. This is especially true if the onset of symptoms are subacute or chronic. The pulmonary side effects of cardiac drugs are varied and may actually mimic the disease being treated. It is essential that the clinician remain highly suspicious that new and unexplained pulmonary symptoms and signs may be drug-related. Most of the side effects are reversible with early drug cessation and subsequent challenge should be avoided if possible | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Allen, M B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drugs of today (Barcelona, Spain : 1998) |d 1998 |g 35(1999), 11 vom: 13. Nov., Seite 867-78 |w (DE-627)NLM123139600 |x 1699-3993 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:1999 |g number:11 |g day:13 |g month:11 |g pages:867-78 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 1999 |e 11 |b 13 |c 11 |h 867-78 | ||